176 related articles for article (PubMed ID: 23723698)
1. Nanoemulsion loaded with lycobetaine-oleic acid ionic complex: physicochemical characteristics, in vitro, in vivo evaluation, and antitumor activity.
Zhao H; Lu H; Gong T; Zhang Z
Int J Nanomedicine; 2013; 8():1959-73. PubMed ID: 23723698
[TBL] [Abstract][Full Text] [Related]
2. A comparison study between lycobetaine-loaded nanoemulsion and liposome using nRGD as therapeutic adjuvant for lung cancer therapy.
Chen T; Gong T; Zhao T; Fu Y; Zhang Z; Gong T
Eur J Pharm Sci; 2018 Jan; 111():293-302. PubMed ID: 28966099
[TBL] [Abstract][Full Text] [Related]
3. Lipid nanoemulsions loaded with doxorubicin-oleic acid ionic complex: characterization, in vitro and in vivo studies.
Zhang X; Sun X; Li J; Zhang X; Gong T; Zhang Z
Pharmazie; 2011 Jul; 66(7):496-505. PubMed ID: 21812324
[TBL] [Abstract][Full Text] [Related]
4. Mannosylated lipid nano-emulsions loaded with lycorine-oleic acid ionic complex for tumor cell-specific delivery.
Guo Y; Liu X; Sun X; Zhang Q; Gong T; Zhang Z
Theranostics; 2012; 2(11):1104-14. PubMed ID: 23227126
[TBL] [Abstract][Full Text] [Related]
5. nRGD modified lycobetaine and octreotide combination delivery system to overcome multiple barriers and enhance anti-glioma efficacy.
Chen T; Song X; Gong T; Fu Y; Yang L; Zhang Z; Gong T
Colloids Surf B Biointerfaces; 2017 Aug; 156():330-339. PubMed ID: 28544965
[TBL] [Abstract][Full Text] [Related]
6. A novel submicron emulsion system loaded with vincristine-oleic acid ion-pair complex with improved anticancer effect: in vitro and in vivo studies.
Zhang T; Zheng Y; Peng Q; Cao X; Gong T; Zhang Z
Int J Nanomedicine; 2013; 8():1185-96. PubMed ID: 23658485
[TBL] [Abstract][Full Text] [Related]
7. Nanostructured oleic acid/polysorbate 80 emulsions with diminished toxicity in NL-20 cell line: Insights of potential drug carriers.
Pérez-González MLL; González-de la Rosa CH; Pérez-Hernández G; Beltrán HI
Colloids Surf B Biointerfaces; 2020 Mar; 187():110758. PubMed ID: 31932123
[TBL] [Abstract][Full Text] [Related]
8. Boosting transdermal delivery of atorvastatin calcium via o/w nanoemulsifying system: Two-step optimization, ex vivo and in vivo evaluation.
Shaker DS; Ishak RAH; Elhuoni MA; Ghoneim AM
Int J Pharm; 2020 Mar; 578():119073. PubMed ID: 31982556
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characteristics of lipid nanoemulsion formulations loaded with doxorubicin.
Jiang SP; He SN; Li YL; Feng DL; Lu XY; Du YZ; Yu HY; Hu FQ; Yuan H
Int J Nanomedicine; 2013; 8():3141-50. PubMed ID: 23990722
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Lycobetaine in Rat Plasma by LC-ESI-MS/MS.
Chen T; Li W; Gong T; Fu Y; Ding R; Gong T; Zhang Z
J Chromatogr Sci; 2017 Mar; 55(3):301-308. PubMed ID: 27903551
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.
Baechler SA; Fehr M; Habermeyer M; Hofmann A; Merz KH; Fiebig HH; Marko D; Eisenbrand G
Bioorg Med Chem; 2013 Feb; 21(3):814-23. PubMed ID: 23266176
[TBL] [Abstract][Full Text] [Related]
12. Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect.
Pangeni R; Choi JU; Panthi VK; Byun Y; Park JW
Int J Nanomedicine; 2018; 13():3329-3351. PubMed ID: 29922055
[TBL] [Abstract][Full Text] [Related]
13. Modification of polyethylene glycol onto solid lipid nanoparticles encapsulating a novel chemotherapeutic agent (PK-L4) to enhance solubility for injection delivery.
Fang YP; Wu PC; Huang YB; Tzeng CC; Chen YL; Hung YH; Tsai MJ; Tsai YH
Int J Nanomedicine; 2012; 7():4995-5005. PubMed ID: 23055719
[TBL] [Abstract][Full Text] [Related]
14. Development, Optimization, and Characterization of PEGylated Nanoemulsion of Prostaglandin E1 for Long Circulation.
Cheng Y; Liu M; Hu H; Liu D; Zhou S
AAPS PharmSciTech; 2016 Apr; 17(2):409-17. PubMed ID: 26195071
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of the interaction of lycobetaine with DNA.
Liu J; Yang SL; Xu B
Zhongguo Yao Li Xue Bao; 1989 Sep; 10(5):437-42. PubMed ID: 2618733
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers.
Li F; Weng Y; Wang L; He H; Yang J; Tang X
Int J Pharm; 2010 Jun; 393(1-2):203-11. PubMed ID: 20385221
[TBL] [Abstract][Full Text] [Related]
17. QbD-based development of α-linolenic acid potentiated nanoemulsion for targeted delivery of doxorubicin in DMBA-induced mammary gland carcinoma: in vitro and in vivo evaluation.
Tripathi CB; Parashar P; Arya M; Singh M; Kanoujia J; Kaithwas G; Saraf SA
Drug Deliv Transl Res; 2018 Oct; 8(5):1313-1334. PubMed ID: 29748834
[TBL] [Abstract][Full Text] [Related]
18. A novel camptothecin derivative incorporated in nano-carrier induced distinguished improvement in solubility, stability and anti-tumor activity both in vitro and in vivo.
Han M; He CX; Fang QL; Yang XC; Diao YY; Xu DH; He QJ; Hu YZ; Liang WQ; Yang B; Gao JQ
Pharm Res; 2009 Apr; 26(4):926-35. PubMed ID: 19048358
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and tissue distribution of etoposide delivered in long circulating parenteral emulsion.
Reddy PR; Venkateswarlu V
J Drug Target; 2005 Dec; 13(10):543-53. PubMed ID: 16390815
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique.
Yu Y; Tan S; Zhao S; Zhuang X; Song Q; Wang Y; Zhou Q; Zhang Z
Int J Nanomedicine; 2013; 8():2641-52. PubMed ID: 23935362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
